Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Array Biopharma Inc (ARRY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,298,116
  • Shares Outstanding, K 221,751
  • Annual Sales, $ 173,770 K
  • Annual Income, $ -147,350 K
  • 60-Month Beta 1.15
  • Price/Sales 37.76
  • Price/Cash Flow N/A
  • Price/Book 21.63

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate -0.16
  • Number of Estimates 8
  • High Estimate -0.11
  • Low Estimate -0.21
  • Prior Year -0.24
  • Growth Rate Est. (year over year) +33.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
20.93 +122.55%
on 05/20/19
47.05 -1.00%
on 06/17/19
+24.72 (+113.08%)
since 05/17/19
3-Month
20.72 +124.81%
on 05/13/19
47.05 -1.00%
on 06/17/19
+22.84 (+96.21%)
since 03/18/19
52-Week
12.56 +270.86%
on 10/11/18
47.05 -1.00%
on 06/17/19
+29.08 (+166.17%)
since 06/18/18

Most Recent Stories

More News
SHAREHOLDER ALERT: WeissLaw LLP Investigates Array BioPharma Acquisition

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Array BioPharma ("Array" or the "Company") (NASDAQ: ARRY) in connection with...

ARRY : 46.58 (+0.30%)
PFE : 43.07 (+0.44%)
Pfizer-Array Biopharma Deal Bump Up Biotech ETFs

Pfizer struck a deal to acquire the cancer drugmaker Array Biopharma for $11 billion in an all-cash consideration.

PBE : 53.06 (+1.12%)
SBIO : 35.93 (+1.61%)
ARKG : 32.10 (+1.36%)
ARRY : 46.58 (+0.30%)
PFE : 43.07 (+0.44%)
XBI : 86.96 (+1.89%)
Pfizer to Buy Array BioPharma, Broaden Cancer Portfolio

Pfizer (PFE) offers $48 per share to buy Array BioPharma and strengthen its cancer portfolio.

ARRY : 46.58 (+0.30%)
LLY : 114.65 (+1.10%)
PFE : 43.07 (+0.44%)
BMY : 47.79 (-0.87%)
Company News For Jun 18, 2019

Companies In The News Are: DISH,TMUS,S,ARRY,PFE,BID,BA

TMUS : 76.44 (+1.55%)
S : 7.23 (+1.83%)
ARRY : 46.58 (+0.30%)
DISH : 39.10 (+0.28%)
BID : 56.21 (+0.14%)
PFE : 43.07 (+0.44%)
BA : 373.96 (+5.37%)
Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Array BioPharma Inc. (NASDAQ: ARRY) on Behalf of Array Shareholders and Encourages Array Investors to Contact the Firm

Bragar Eagel & Squire, P.C. is investigating potential claims against the board of directors of Array BioPharma, Inc. (NASDAQ: ARRY) on behalf of Array shareholders concerning the proposed merger with...

ARRY : 46.58 (+0.30%)
PFE : 43.07 (+0.44%)
SmarTrend Watching for Potential Pullback in Shares of Array Biopharma After 56.94% Gain

Array Biopharma (NASDAQ:ARRY) traded in a range yesterday that spanned from a low of $28.85 to a high of $47.22. Yesterday, the shares gained 56.9%, which took the trading range above the 3-day high...

ARRY : 46.58 (+0.30%)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Array BioPharma Inc. to Pfizer Inc. is Fair to Shareholders

The following statement is being issued by Levi & Korsinsky, LLP:

ARRY : 46.58 (+0.30%)
PFE : 43.07 (+0.44%)
Big Ticket Mergers Are in Focus

Big Ticket Mergers Are in Focus

TMUS : 76.44 (+1.55%)
S : 7.23 (+1.83%)
ARRY : 46.58 (+0.30%)
PFE : 43.07 (+0.44%)
ARRAY BIOPHARMA INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout

Rigrodsky & Long, P.A.:

ARRY : 46.58 (+0.30%)
PFE : 43.07 (+0.44%)
"Merger Monday" Returns: Pfizer Buying Array, T-Mobile-Sprint on Ice?

News on two major mergers in their respective industries are taking headlines, along with a fresh regional economic read.

TMUS : 76.44 (+1.55%)
S : 7.23 (+1.83%)
ARRY : 46.58 (+0.30%)
PFE : 43.07 (+0.44%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is in the Top 1%. Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade ARRY with:

Business Summary

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat life threatening and debilitating diseases. The company's proprietary drug development pipeline is focused on the treatment of cancer and inflammatory...

See More

Key Turning Points

2nd Resistance Point 47.13
1st Resistance Point 46.86
Last Price 46.58
1st Support Level 46.35
2nd Support Level 46.11

See More

52-Week High 47.05
Last Price 46.58
Fibonacci 61.8% 33.87
Fibonacci 50% 29.81
Fibonacci 38.2% 25.74
52-Week Low 12.56

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar